The DOI matches its Crossref record; 169 of the 171 references it cites were found in a registry or an index.
The Sympathetic Nervous System in Heart Failure
Open accessAbstract
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers countermeasures aimed to restore cardiac output. These responses are compensatory at first but eventually become part of the disease process itself leading to further worsening cardiac function. Among these responses is the activation of the sympathetic nervous system (SNS) that provides inotropic support to the failing heart increasing stroke volume, and peripheral vasoconstriction to maintain mean arterial perfusion pressure, but eventually accelerates disease progression affecting survival. Activation of SNS has been attributed to withdrawal of normal restraining influences and enhancement of excitatory inputs including changes in: 1) peripheral baroreceptor and chemoreceptor reflexes; 2) chemical mediators that control sympathetic outflow; and 3) central integratory sites. The interface between the sympathetic fibers and the cardiovascular system is formed by the adrenergic receptors (ARs). Dysregulation of cardiac beta(1)-AR signaling and transduction are key features of heart failure progression. In contrast, cardiac beta(2)-ARs and alpha(1)-ARs may function in a compensatory fashion to maintain cardiac inotropy. Adrenergic receptor polymorphisms may have an impact on the adaptive mechanisms, susceptibilities, and pharmacological responses of SNS. The beta-AR blockers and the inhibitors of the renin-angiotensin-aldosterone axis form the mainstay of current medical management of chronic heart failure. Conversely, central sympatholytics have proved harmful, whereas sympathomimetic inotropes are still used in selected patients with hemodynamic instability. This review summarizes the changes in SNS in heart failure and examines how modulation of SNS activity may affect morbidity and mortality from this syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreased cardiac output and the resulting sympathetic vasoconstriction in heart failure stimulates adaptive re-distribution of the systemic circulation, leading to congestion in multiple end organs, including the bowel wall31.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Lechat, P. P., Brunhuber, K., Hofmann, R., Kuhn, P., Nesser, H., Slany, J., Weihs, W., Wiedermann, C. J., Wimmer, H., van Mieghem, W., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,922
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,137
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
Wittstein, I. S., Thiemann, D. R., Lima, J. A. C., Baughman, K. L., Schulman, S. P., Gerstenblith, G., Wu, K. C., Rade, J. J., Bivalacqua, T. J., & Champion, H. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043046 · Cited by 3,108
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W. A., Cubicciotti, R. S., Sageman, W. S., Lurie, K. G., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Cited by
Sorted by citations
Items 201–300 of 979
Grosman‐Rimon, L., Jacobs, I. A., Tumiati, L. C., McDonald, M. A., Bar-Ziv, S. P., Fuks, A., Kawajiri, H., Lazarte, J., Ghashghai, A., Shogilev, D. J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.12.006 · Cited by 39
Hu, W. G., Jin, X., Zhāng, P., Yu, Q., Yin, G., Lu, Y., Xiao, H., Chen, Y., & Zhang, D. (2016) · Scientific Reports · doi:10.1038/srep23617 · Cited by 41
Kataoka, H. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12191 · Cited by 39
Kan, H., Pan, D., & Castranova, V. (2018) · Inhalation Toxicology · doi:10.1080/08958378.2018.1535634 · Cited by 39
Cardiorenal syndrome in acute decompensated heart failure
Aronson, D. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.193 · Cited by 39
Pellegrino, T., Petretta, M., Luca, S. D., Paolillo, S., Boemio, A., Carotenuto, R., Petretta, M. P., di Nuzzo, C., Filardi, P. P., & Cuocolo, A. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2461-4 · Cited by 38
Autonomic Dysfunction in Diabetes: a Consequence of Cardiovascular Damage
Lefrandt, J. D., Smit, A. J., Zeebregts, C. J., Gans, R. O. B., & Hoogenberg, K. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793499128 · Cited by 38
Aisu, H., Saito, M., Inaba, S., Morofuji, T., Takahashi, K., Sumimoto, T., Okura, T., & Higaki, J. (2016) · Hypertension Research · doi:10.1038/hr.2016.116 · Cited by 38
Impact of Renal Denervation on Atrial Arrhythmogenic Substrate in Ischemic Model of Heart Failure
Yamada, S., Fong, M., Hsiao, Y., Chang, S., Tsai, Y.-N., Lo, L., Chao, T., Lin, Y., Hu, Y., Chung, F., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007312 · Cited by 39
Myocardial Energy Stress, Autophagy Induction, and Cardiomyocyte Functional Responses
Daniels, L. J., Varma, U., Annandale, M., Chan, E., Mellor, K. M., & Delbridge, L. M. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7650 · Cited by 38
Adrenergic receptor activation involves ATP release and feedback through purinergic receptors
Sumi, Y., Woehrle, T., Chen, Y., Yao, Y., Li, A. A., & JUNGER, W. G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00122.2010 · Cited by 38
Structural abnormality of the hippocampus associated with depressive symptoms in heart failure rats
Suzuki, H., Sumiyoshi, A., Matsumoto, Y., Duffy, B. A., Yoshikawa, T., Lythgoe, M. F., Yanai, K., Taki, Y., Kawashima, R., & Shimokawa, H. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.10.040 · Cited by 35
Molecular and cellular neurocardiology in heart disease
Habecker, B. A., Bers, D. M., Birren, S. J., Chang, R. B., Herring, N., Kay, M. W., Li, D., Mendelowitz, D., Mongillo, M., Montgomery, J. M., et al. (2024) · The Journal of Physiology · doi:10.1113/jp284739 · Cited by 40
Effects of Renal Sympathetic Denervation on Post-Myocardial Infarction Cardiac Remodeling in Rats
Hu, J., Ji, M., Niu, C., Aini, A., Zhou, Q., Zhang, L., Jiang, T., Yan, Y., & Hou, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045986 · Cited by 37
Farré, N., Aranyo, J. A., Enjuanes, C., Verdú-Rotellar, J. M., Ruiz, S., González-Robledo, G., Meroño, O., Ramón, M., Moliner, P., Bruguera, J., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.025 · Cited by 37
Zhang, C., Shan, X., Liao, Y., Zhao, P., Guo, W., Hong-chang, W., & Lü, R. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-474 · Cited by 37
Wang, C., Xiong, B., & Huang, J. (2016) · Nutrients · doi:10.3390/nu9010018 · Cited by 38
The Biological Role of Nestin(+)-Cells in Physiological and Pathological Cardiovascular Remodeling
Calderone, A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00015 · Cited by 38
Zhao, W., Lu, Q., Nguyen, M., Su, Y., Ziemann, M., Wang, L., Kiriazis, H., Puthalakath, H., Sadoshima, J., Hu, H., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14674 · Cited by 37
Nutrient sensing and utilization: getting to the heart of metabolic flexibility
Griffin, T. M., Humphries, K. M., Kinter, M., Lim, H.-Y., & Szweda, L. I. (2016) · Biochimie · doi:10.1016/j.biochi.2015.10.013 · Cited by 36
The emotion paradox in the aging body and brain
Mather, M. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15138 · Cited by 38
Kleemann, T., Hochadel, M., Strauss, M., Skarlos, A., Seidl, K., & Zahn, R. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02279.x · Cited by 36
Carotid Body-Mediated Chemoreflex Drive in The Setting of low and High Output Heart Failure
Río, R. D., Andrade, D. C., Toledo, C., Díaz, H. S., Lucero, C. M. J., Arce‐Álvarez, A., Marcus, N. J., & Schultz, H. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-08142-3 · Cited by 36
Exercise training in pulmonary arterial hypertension
Vecchia, L. A. D., & Bussotti, M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.01.90 · Cited by 36
Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions
Cunha, G., Rocha, B. M. L., & Falcão, L. M. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.04.013 · Cited by 36
Ostrowski, S. R., Berg, R. M. G., Windeløv, N. A., Meyer, M., Plovsing, R. R., Møller, K., & Johansson, P. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059368 · Cited by 35
Obesity, Heart Failure, and Obesity Paradox.
Hamzeh, N., Ghadimi, F., Farzaneh, R., & Hosseini, S. K. (2017) · PubMed Central · Cited by 34
Tajes, M., Díez‐López, C., Enjuanes, C., Moliner, P., Ferreiro, J. L., Garay, A., Jiménez‐Marrero, S., Yun, S., Sosa, S. G., Alcoberro, L., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00605-5 · Cited by 35
Acute Heart Failure: Patient Characteristics and Pathophysiology
Marti, C. N., Georgiopoulou, V. V., & Kalogeropoulos, A. P. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0151-y · Cited by 34
Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke
Mira, K., Moon, Y. P., Paik, M. C., Müeller, B., Huber, A., Sacco, R. L., & Elkind, M. S. V. (2016) · Stroke · doi:10.1161/strokeaha.115.011392 · Cited by 34
Fukuta, H., Goto, T., Wakami, K., & Ohte, N. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9629-0 · Cited by 34
Neuroimmune interactions in cardiovascular diseases
Carnevale, D., & Lembo, G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa151 · Cited by 34
Pathophysiology of Fluid Retention in Heart Failure
Chaney, E., & Shaw, A. (2010) · Contributions to nephrology · doi:10.1159/000313720 · Cited by 34
Boogers, M. J., Fukushima, K., Bengel, F. M., & Bax, J. J. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9196-0 · Cited by 33
Cardiac telomere length in heart development, function, and disease
Booth, S. A., & Charchar, F. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2017 · Cited by 33
The control mechanisms of heart rate dynamics in a new heart rate nonlinear time series model
He, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-61562-6 · Cited by 37
Schulz, R., & Schlüter, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076459 · Cited by 33
Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure
Toschi‐Dias, E., Rondon, M. U. P. B., Cogliati, C. B., Paolocci, N., Tobaldini, E., & Montano, N. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00162 · Cited by 34
Chen, Y., Pu, W., Maswikiti, E. P., Tao, P., Li, X., Wang, D., Gu, B., Yu, Y., Gao, L., Zhao, C., et al. (2021) · Bioscience Reports · doi:10.1042/bsr20211560 · Cited by 34
Zaccolo, M., & Kovanich, D. (2024) · Physiological Reviews · doi:10.1152/physrev.00013.2024 · Cited by 35
Renal Function in Advanced Heart Failure
Giamouzis, G., Butler, J., & Triposkiadis, F. K. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00240.x · Cited by 33
Self-citationBatacan, R. B., Duncan, M. J., Dalbo, V. J., Buitrago, G., & Fenning, A. S. (2016) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2016.08.001 · Cited by 34
Hoeker, G. S., Hood, A. R., Katra, R. P., Poelzing, S., & Pogwizd, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111411 · Cited by 32
Audet, M., Lagacé, M., Silversides, D. W., & Bouvier, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-144816 · Cited by 32
Beta‐Blocker Use Is Associated With Impaired Left Atrial Function in Hypertension
Sardana, M., Syed, A. A., Hashmath, Z., Phan, T. S., Koppula, M. R., Kewan, U., Ahmed, Z., Chandamuri, R., Varakantam, S., Shah, E., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005163 · Cited by 32
Karayannis, G., Triposkiadis, F. K., Skoularigis, J. S., Georgoulias, P., Butler, J., & Giamouzis, G. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0169-1 · Cited by 31
Self-citationKataoka, H. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.005 · Cited by 31
PET and PET/CT in cardiovascular disease
Gaemperli, O., & Kaufmann, P. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06030.x · Cited by 31
Sympathetic Nervous System Activation and β-Adrenoceptor Blockade in Right Heart Failure
Andersen, S., Andersen, A., de Man, F. S., & Nielsen‐Kudsk, J. E. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.253 · Cited by 31
Subjective social status predicts in vivo responsiveness of β-adrenergic receptors.
Euteneuer, F., Mills, P. J., Rief, W., Ziegler, M. G., & Dimsdale, J. E. (2011) · Health Psychology · doi:10.1037/a0025990 · Cited by 31
Aging‐associated atrial fibrillation: A comprehensive review focusing on the potential mechanisms
Wang, M., Hou, C., Jia, F., Zhong, C., Xue, C., & Li, J. (2024) · Aging Cell · doi:10.1111/acel.14309 · Cited by 33
Exercise Training in Heart Failure: Clinical Benefits and Mechanisms
Mounsey, L. A., Guo, M., Lau, E. S., & Ho, J. E. (2025) · Circulation Research · doi:10.1161/circresaha.124.325533 · Cited by 36
Kim, Y., Canada, J. M., Kenyon, J. D., Billingsley, H., Arena, R. A., Lavie, C. J., & Carbone, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271238 · Cited by 32
Neto, S. R. M., Silva, A. D. H., dos Santos, M. C. P., Ferraz, E., & Nascimento, J. H. M. (2012) · Acta Physiologica · doi:10.1111/apha.12056 · Cited by 30
Vettel, C., Wittig, K., Vogt, A., Wuertz, C. M., El‐Armouche, A., Lutz, S., & Wieland, T. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.04.015 · Cited by 30
Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections
Conway, E. L., Sellick, J. A., Kurtzhalts, K. E., & Mergenhagen, K. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02389-16 · Cited by 30
Lin, C. D., Tona, F., & Osto, E. (2015) · International Journal of Endocrinology · doi:10.1155/2015/312848 · Cited by 30
Heart Failure as a Disruption of Dynamic Circulatory Homeostasis Mediated by the Brain
Kishi, T. (2016) · International Heart Journal · doi:10.1536/ihj.15-517 · Cited by 29
Ablation of brainstem C1 neurons improves cardiac function in volume overload heart failure
Andrade, D. C., Toledo, C., Díaz, H. S., Lucero, C. M. J., Arce‐Álvarez, A., Oliveira, L. M., Takakura, A. C. T., Moreira, T. S., Schultz, H. D., Marcus, N. J., et al. (2019) · Clinical Science · doi:10.1042/cs20180589 · Cited by 29
Chen, S., Jing, Y., Zhang, J., Jiang, M., Hu, T.-Q., Leng, W., Li, X., Li, X., Zhang, L., Zheng, F., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1160-x · Cited by 29
Nuclear imaging in detection and monitoring of cardiotoxicity
D’Amore, C. (2014) · World Journal of Radiology · doi:10.4329/wjr.v6.i7.486 · Cited by 29
Gouweleeuw, L., Hovens, I. B., Liu, H., Naudé, P. J. W., & Schoemaker, R. G. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.04.040 · Cited by 29
Radionuclide Imaging of Neurohormonal System of the Heart
Chen, X., Werner, R. A., Javadi, M. S., Maya, Y., Decker, M. W., Lapa, C., Herrmann, K., & Higuchi, T. (2015) · Theranostics · doi:10.7150/thno.10900 · Cited by 28
New medications for heart failure
Gordin, J. S., & Fonarow, G. C. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.008 · Cited by 29
Beneficial Effect of Renal Denervation on Ventricular Premature Complex Induced Cardiomyopathy
Yamada, S., Lo, L., Chou, Y., Lin, W., Chang, S., Lin, Y., Liu, S.-H., Cheng, W., Tsai, T., & Chen, S. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004479 · Cited by 29
Argunhan, F., & Brain, S. D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.833645 · Cited by 31
Mechanisms for the cardiovascular effects of glucagon-like peptide-1
Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 27
The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
Triposkiadis, F. K., Starling, R. C., Boudoulas, H. K., Giamouzis, G., & Butler, J. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9291-x · Cited by 27
Self-citationMeana, C., Rubín, J. M., Bordallo, C., Suárez, L., Bordallo, J., & Sánchez, M. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12674 · Cited by 28
Yamada, S., Lo, L., Chou, Y., Lin, W.-L., Chang, S., Lin, Y., & Chen, S.-A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.085 · Cited by 28
Apaiajai, N., Chunchai, T., Jaiwongkam, T., Kerdphoo, S., Chattipakorn, S. C., & Chattipakorn, N. (2018) · Gerontology · doi:10.1159/000487188 · Cited by 28
Cardioprotective effect of histamine H2 antagonists in congestive heart failure
Zhang, J., Cai, W.-K., Zhang, Z., Wang, P., Lin, X., Ju, F., Fu, S., & He, G. (2018) · Medicine · doi:10.1097/md.0000000000010409 · Cited by 28
Cardiac Radionuclide Imaging to Assess Patients With Heart Failure
Travin, M. I. (2014) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.04.005 · Cited by 27
Caldas, J. R., Panerai, R. B., Salinet, A. M., Bor‐Seng‐Shu, E., Ferreira, G. S. R., CÂMARA, L. A. F. C. D., Passos, R. H., Galas, F. R. B. G., de Almeida, J. P., Nogueira, R. D. C., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00727.2017 · Cited by 27
When blood pressure refuses to budge: exploring the complexity of resistant hypertension
Champaneria, M. K., Patel, R., & Oroszi, T. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1211199 · Cited by 30
Doiron, J. E., Li, Z., Yu, X., LaPenna, K. B., Quiriarte, H. D., Allerton, T. D., Koul, K., Malek, A. J., Shah, S. J., Sharp, T. E., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032646 · Cited by 25
Karayannis, G., Giamouzis, G., Tziolas, N., Georgoulias, P., Skoularigis, J. S., Mikhailidis, D. P., & Triposkiadis, F. K. (2012) · Angiology · doi:10.1177/0003319712447978 · Cited by 27
Self-citationKapelios, C. J., Kaldara, E. E., Ntalianis, A., Nana, E., Pantsios, C., Repasos, E., Margari, Z. J., Sousonis, V., Malliaras, K. G., & Nanas, J. N. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.156 · Cited by 27
The Sympathorenal Axis in Hypertension and Heart Failure
Goldsmith, S. R., Sobotka, P. A., & Bart, B. A. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.12.022 · Cited by 27
β‐Adrenoceptor activation affects galectin‐3 as a biomarker and therapeutic target in heart disease
Du, X., Zhao, W., Nguyen, M., Lu, Q., & Kiriazis, H. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14620 · Cited by 27
Fukuta, H., Goto, T., Wakami, K., Kamiya, T., & Ohte, N. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09974-4 · Cited by 27
Tachycardia and Atrial Fibrillation-Related Cardiomyopathies
Keefe, J. A., Garber, R., McCauley, M. D., & Wehrens, X. H. T. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2023.11.016 · Cited by 26
Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure
Jiang, Y., Gu, J., Niu, X., Hu, J., Zhang, Y., Li, D., Tang, Y., Liu, C., & Li, Z. (2024) · Circulation · doi:10.1161/circulationaha.123.067519 · Cited by 26
Ajijola, O. A., Aksu, T., Arora, R., Biaggioni, I., Chen, P., Ferrari, G. M. D., Dusi, V., Fudim, M., Goldberger, J. J., Green, A. L., et al. (2025) · The Journal of Physiology · doi:10.1113/jp284741 · Cited by 31
Sailer, C. L., Edelmann, H., Buchanan, C., Giro, P., Babcock, M. C., Swanson, C. M., Spotts, M., Schulte, M., Pratt-Cordova, A., Coe, G., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007448 · Cited by 26
Piedra, L. M., Andrade, F. C. D., Hernández, R., Perreira, K. M., Gallo, L. C., González, H. M., González, S. R., Cai, J., Chen, J., Castañeda, S. F., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.119.012704 · Cited by 25
Association Between Serum Sodium Level Trajectories and Survival in Patients with Heart Failure
Xia, Y., Wang, S., Wu, W.-D., & Liang, J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14187 · Cited by 26
Martinez, A., Lakkimsetti, M., Maharjan, S., Aslam, M. A., Basnyat, A., Kafley, S., Reddy, S. S., Ahmed, S. S., Razzaq, W., Adusumilli, S., et al. (2023) · Cureus · doi:10.7759/cureus.44043 · Cited by 26
Impact of diabetes mellitus on lymphocyte GRK 2 protein levels in patients with heart failure
Rengo, G., Pagano, G., Paolillo, S., de Lucia, C., Femminella, G. D., Liccardo, D., Cannavò, A., Formisano, R., Petraglia, L., Komici, K., et al. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12395 · Cited by 26
Pereira, S. B., Velloso, M. W. M., Chermont, S., Quintão, M., ABDHALA, R. N., Giro, C., Alves, T. D. O. E., Camacho, V., CONTARATO, L. D. F. M., Pena, F. M., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1120 · Cited by 26
Substrates and potential therapeutics of ventricular arrhythmias in heart failure
Zhang, D., Tu, H., Wadman, M. C., & Li, Y. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.024 · Cited by 27
Epidemiology and Importance of Renal Dysfunction in Heart Failure Patients
Giamouzis, G., Kalogeropoulos, A. P., Butler, J., Karayannis, G., Georgiopoulou, V. V., Skoularigis, J. S., & Triposkiadis, F. K. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0164-6 · Cited by 25
Self-citationSun, S., Kee, H. J., Ryu, Y., Choi, S. Y., Kim, G. R., Kim, H.-S., Kee, S., & Jeong, M. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-39423-8 · Cited by 25
Luo, R., Zheng, C., Yang, H., Chen, X., Jiang, P., Wu, X., Yang, Z., Shen, X., & Li, X. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.25 · Cited by 25
Central Mechanisms of Abnormal Sympathoexcitation in Chronic Heart Failure
Kishi, T., & Hirooka, Y. (2012) · Cardiology Research and Practice · doi:10.1155/2012/847172 · Cited by 26
Chen, L., Zhou, Q., Jin, H. L., Zhu, K., Zhi, H., Chen, Z., & Ma, G. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.03.164 · Cited by 25
Joca, H. C., Santos‐Miranda, A., Joviano-Santos, J. V., Maia-Joca, R. P. M., Brum, P. C., Williams, G. S. B., & Cruz, J. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-64949-7 · Cited by 24
Sato, Y., Yoshihisa, A., Oikawa, M., Nagai, T., Yoshikawa, T., Saito, Y., Yamamoto, K., Takeishi, Y., & Anzai, T. (2019) · International Heart Journal · doi:10.1536/ihj.18-699 · Cited by 24
Río, R. D., Andrade, D. C., Marcus, N. J., & Schultz, H. D. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.079566 · Cited by 24
Zhang, K., Tang, Y., Zhang, Y., Ojamaa, K., Li, Y., Saini, A. S., Carrillo-Sepúlveda, M. A., Rajagopalan, V., & Gerdes, A. M. (2018) · Thyroid · doi:10.1089/thy.2017.0544 · Cited by 24
Metadata
- Authors
- Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J.
- Affiliations
- University Hospital of Larissa (GR)
- Emory University (US)
- AHEPA University Hospital (GR)
- Corresponding author
- Butler, Javed
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 54
- Issue
- 19
- Pages
- 1747-1762
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2097757382
- Cited by
- 978
- References
- 171
- Citations by year
- 2026: 40 · 2025: 44 · 2024: 69 · 2023: 46 · 2022: 74 · 2021: 54 · 2020: 59 · 2019: 77 · 2018: 59 · 2017: 62 · 2016: 71 · 2015: 66 · 2014: 63 · 2013: 58 · 2012: 61
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- heart failure, sympathetic nervous system, sympathetic activation, left ventricular dysfunction, beta1-adrenergic receptor, beta2-adrenergic receptor, alpha1-adrenoceptors, baroreflex, chemoreceptor reflex, beta-blockers, renin-angiotensin-aldosterone system inhibitors, cardiac inotropy, disease progression
- MeSH terms
- Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Cardiotonic Agents, Digoxin, Heart Failure, Hemodynamics, Humans, Parasympathetic Nervous System, Polymorphism, Genetic, Receptors, Adrenergic, Renin-Angiotensin System, Sympathetic Nervous System, Sympatholytics, Sympathomimetics, Randomized Controlled Trials as Topic, Exercise Tolerance, Receptors, Adrenergic, alpha-1, Receptors, Adrenergic, beta-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
